Grant: Discovery Grants Program - Individual
University of British Columbia
$33,000.00
New methods for the efficient syntheses of complex natural products
EF 2008-09
Résumé
Nature provides a wealth of complex chemical compounds that have the potential to serve as new medicines and treatments. While many of these natural products can be isolated in large quantities, many potentially bioactive compounds are only available in minute amounts. Chemical total synthesis provides a means of accessing these compounds for both pharmaceutical evaluation and for the synthesis of medicinally relevant analogs. Even with modern synthetic technology, many architecturally complex natural products can still not be synthesized in sufficient quantities for testing as medicines.
A "family" of natural products consists of compounds containing comparable core structures with only slight structural variations. This new research program will focus on developing new synthetic technology for the synthesis of the central framework (or core) within a bioactive molecule. The newly developed methodology is then not only immediately applicable toward the synthesis of the original compound, but can also be used to synthesize the entire family of related natural products. The synthetic technology developed in this research program has the potential to unlock access to previously unavailable architecturally unique compounds in sufficient quantities for medicinal testing. Success in this target-directed methodological development has great potential to boost Canada's pharmaceutical and biotechnology industries.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
341648-2007
Name nom
Sammis, Glenn
Department département
Chemistry
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2007
Award amount
33000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
24
Committee name en
Inorganic & Organic Chemistry
Committee name fr
Chimie inorg. et org.
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3704
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Synthetic methodology
Research subject fr
Méthodologie en synthèse
Partie
2
Nb partie
3
Application title
New methods for the efficient syntheses of complex natural products
Keyword
NA
Application summary
Nature provides a wealth of complex chemical compounds that have the potential to serve as new medicines and treatments. While many of these natural products can be isolated in large quantities, many potentially bioactive compounds are only available in minute amounts. Chemical total synthesis provides a means of accessing these compounds for both pharmaceutical evaluation and for the synthesis of medicinally relevant analogs. Even with modern synthetic technology, many architecturally complex natural products can still not be synthesized in sufficient quantities for testing as medicines.
A "family" of natural products consists of compounds containing comparable core structures with only slight structural variations. This new research program will focus on developing new synthetic technology for the synthesis of the central framework (or core) within a bioactive molecule. The newly developed methodology is then not only immediately applicable toward the synthesis of the original compound, but can also be used to synthesize the entire family of related natural products. The synthetic technology developed in this research program has the potential to unlock access to previously unavailable architecturally unique compounds in sufficient quantities for medicinal testing. Success in this target-directed methodological development has great potential to boost Canada's pharmaceutical and biotechnology industries.